Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

被引:66
作者
delaConcha, EG
Arroyo, R
Crusius, JBA
Campillo, JA
Martin, C
deSeijas, E
Pena, AS
Claveria, LE
FernandezArquero, M
机构
[1] SAN CARLOS UNIV HOSP, DEPT NEUROL, MADRID, SPAIN
[2] FREE UNIV AMSTERDAM HOSP, DEPT GASTROENTEROL, AMSTERDAM, NETHERLANDS
[3] GEN HOSP, DEPT NEUROL, SEGOVIA, SPAIN
关键词
interleukin-1 receptor antagonist gene; multiple sclerosis; HLA class II genotyping; disease susceptibility;
D O I
10.1016/S0165-5728(97)00153-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to multiple sclerosis (MS) is associated with HLA-DRB1*1501. Many reports have suggested associations with other loci bur these results remain unconfirmed. We studied the IL-1 receptor antagonist (IL-1ra) gene polymorphism and the HLA-DR and DQ allele frequencies by DNA-based methods in both the primary chronic progressive form (PP MS) and the relapsing/remitting form (R/R MS). The frequency of DRB1*1501 and IL-1ra allele 2 were significantly higher in R/R MS. Association was more marked in the female sex and in patients with benign forms of R/R MS. On the other hand DR4 subtypes carrying a Val at position 86 in the DR beta chain were increased in PP MS. The present study indicates that RIS is genetically heterogeneous and shows a combined effect of HLA-DR and IL-1ra genes in susceptibility to the R/R form of the disease. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 37 条
  • [1] ASSOCIATION OF SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS IN SWEDEN WITH HLA CLASS-II DRB1 AND DQB1 ALLELES
    ALLEN, M
    SANDBERGWOLLHEIM, M
    SJOGREN, K
    ERLICH, HA
    PETTERSON, U
    GYLLENSTEN, U
    [J]. HUMAN IMMUNOLOGY, 1994, 39 (01) : 41 - 48
  • [2] THE GERMLINE REPERTOIRE OF T-CELL RECEPTOR BETA-CHAIN GENES IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS
    BEALL, SS
    CONCANNON, P
    CHARMLEY, P
    MCFARLAND, HF
    GATTI, RA
    HOOD, LE
    MCFARLIN, DE
    BIDDISON, WE
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1989, 21 (01) : 59 - 66
  • [3] Multiple loci for multiple sclerosis
    Bell, JI
    Lathrop, GM
    [J]. NATURE GENETICS, 1996, 13 (04) : 377 - 378
  • [4] THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS
    CANNELLA, B
    RAINE, CS
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (04) : 424 - 435
  • [5] GENES AND SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS
    COMPSTON, DAS
    WOOD, HK
    ROBERTSON, N
    SAWCER, S
    WOOD, NW
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 : 43 - 51
  • [6] INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AND MULTIPLE-SCLEROSIS
    CRUSIUS, JBA
    PENA, AS
    VANOOSTEN, BW
    BIOQUE, G
    GARCIA, A
    DIJKSTRA, CD
    POLMAN, CH
    [J]. LANCET, 1995, 346 (8980): : 979 - 980
  • [7] A full genome search in multiple sclerosis
    Ebers, GC
    Kukay, K
    Bulman, DE
    Sadovnick, AD
    Rice, G
    Anderson, C
    Armstrong, H
    Cousin, K
    Bell, RB
    Hader, W
    Paty, DW
    Hashimoto, S
    Oger, J
    Duquette, P
    Warren, S
    Gray, T
    OConnor, P
    Nath, A
    Auty, A
    Metz, L
    Francis, G
    Paulseth, JE
    Murray, TJ
    PrysePhillips, W
    Nelson, R
    Freedman, M
    Brunet, D
    Bouchard, JP
    Hinds, D
    Risch, N
    [J]. NATURE GENETICS, 1996, 13 (04) : 472 - 476
  • [8] Genetic predisposition to multiple sclerosis as revealed by immunoprinting
    Epplen, C
    Jackel, S
    Santos, EJM
    DSouza, M
    Poehlau, D
    Dotzauer, B
    Sindern, E
    Haupts, M
    Rude, KP
    Weber, F
    Stover, J
    Poser, S
    Gehler, W
    Malin, JP
    Przuntek, H
    Epplen, JT
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (03) : 341 - 352
  • [9] Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland
    Haegert, DG
    Swift, FV
    Benedikz, J
    [J]. NEUROLOGY, 1996, 46 (04) : 1107 - 1111
  • [10] HLA-DQA1 AND HLA-DQB1 ASSOCIATIONS WITH MULTIPLE-SCLEROSIS IN SARDINIA AND FRENCH-CANADA - EVIDENCE FOR IMMUNOGENETICALLY DISTINCT PATIENT GROUPS
    HAEGERT, DG
    MUNTONI, F
    MURRU, MR
    COSTA, G
    FRANCIS, GS
    MARROSU, MG
    [J]. NEUROLOGY, 1993, 43 (03) : 548 - 552